Aurora Cannabis Advances Auto-Flowering Research

Ticker: ACB · Form: 6-K · Filed: 2024-09-17T00:00:00.000Z

Sentiment: neutral

Topics: R&D, cannabis, cultivation

TL;DR

Aurora Cannabis is making strides in auto-flowering tech, potentially boosting cultivation efficiency.

AI Summary

Aurora Cannabis Inc. announced on September 17, 2024, that it has made significant advancements in its auto-flowering research, unveiling key insights into cannabinoid and terpene production. The company's CEO, Miguel Martin, highlighted the potential of this research to drive innovation and efficiency in cannabis cultivation.

Why It Matters

This research could lead to more efficient and cost-effective cannabis cultivation methods, potentially impacting the company's profitability and market position.

Risk Assessment

Risk Level: low — This filing is an informational update on research and development, not a financial event with immediate market-moving implications.

Key Players & Entities

FAQ

What specific insights has Aurora Cannabis unveiled regarding cannabinoid and terpene production in their auto-flowering research?

The filing states that Aurora Cannabis has unveiled 'key insights' into cannabinoid and terpene production, but does not provide specific details within the provided text.

What is the significance of auto-flowering research for Aurora Cannabis?

The research is expected to drive innovation and efficiency in cannabis cultivation, potentially leading to improved production methods.

Who is Miguel Martin and what is his role at Aurora Cannabis?

Miguel Martin is the Chief Executive Officer (CEO) of Aurora Cannabis Inc.

What type of report is this 6-K filing?

This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

What exhibits are included with this 6-K filing?

The filing includes Exhibit 99.1, a News Release dated September 17, 2024.

From the Filing

0001279569-24-001129.txt : 20240917 0001279569-24-001129.hdr.sgml : 20240917 20240917071940 ACCESSION NUMBER: 0001279569-24-001129 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240917 FILED AS OF DATE: 20240917 DATE AS OF CHANGE: 20240917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241302586 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated September 17, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: September 17, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED SEPTEMBER 17, 2024 Exhibit 99.1 Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB, Sept. 17, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology. Auto-flowering is a genetic characteristic that automatically transitions the plant from the vegetative stage to the flowering stage rather than relying on changes in light cycles. This innovative work provides foundational insight on flowering mechanism in cannabis, which will support future breeding strategies, and can be leveraged to revolutionize outdoor cannabis cultivation in high-latitude regions, such as Canada. "As a company backed by science, we have long invested in research both independently and with leading academic institutions, and have achieved significant learning from our work," says Jose Celedon, PhD, Director, Breeding and Genetics at Aurora. "Our recent work on auto-flowering will be a gamechanger for cannabis and hemp production. This research speaks to our expertise and investment in science that will move this industry forward." Most of the commercially grown cannabis is photoperiod sensitive, meaning that plants require shifts in day length to trigger flowering. While this can be controlled readily in indoor production, it is a limitation for outdoor cultivation, especially in high-latitude regions. Aurora has received a US Patent 12,002,546, "Methods of Determining Sensitivity to Photoperiod in Cannabis", which enables Aurora's breeding program to identify and select for the auto flowering trait. This latest research solidifies Aurora's position as an innovative industry leader, poised to shape the future of cannabis agriculture. Aurora's commitment to research and innovation has generated tangible results for

View on Read The Filing